CITIGROUP INC - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$27,089
-15.0%
2,630
+36.1%
0.00%
Q2 2023$31,856
+154.6%
1,933
+41.5%
0.00%
Q1 2023$12,513
+139.7%
1,366
+87.4%
0.00%
Q4 2022$5,220
+74.0%
729
+10.6%
0.00%
Q3 2022$3,000
+50.0%
659
-23.3%
0.00%
Q2 2022$2,000
-75.0%
859
-30.0%
0.00%
Q1 2022$8,000
-42.9%
1,227
-29.8%
0.00%
Q4 2021$14,000
-94.2%
1,747
-92.9%
0.00%
Q3 2021$243,000
+912.5%
24,762
+599.3%
0.00%
Q2 2021$24,000
+140.0%
3,541
+217.9%
0.00%
Q1 2021$10,000
-23.1%
1,114
-41.7%
0.00%
Q4 2020$13,000
+160.0%
1,912
+11.2%
0.00%
Q2 2019$5,0000.0%1,720
-50.0%
0.00%
Q1 2019$5,000
-44.4%
3,4380.0%0.00%
Q4 2018$9,000
-40.0%
3,4380.0%0.00%
Q3 2018$15,000
-28.6%
3,4380.0%0.00%
Q2 2018$21,000
-19.2%
3,438
-5.0%
0.00%
Q1 2018$26,000
-33.3%
3,619
-23.6%
0.00%
Q4 2017$39,000
-61.8%
4,735
-51.5%
0.00%
Q3 2017$102,000
-16.4%
9,765
-11.9%
0.00%
Q2 2017$122,000
+5.2%
11,090
-6.9%
0.00%
Q1 2017$116,00011,9180.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 985,210$10,345,0006.10%
Broadfin Capital, LLC 3,568,122$37,465,0005.54%
JW Asset Management, LLC 444,439$4,667,0003.42%
ARMISTICE CAPITAL, LLC 1,688,000$17,724,0002.09%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,655,494$38,383,0001.73%
FALCON POINT CAPITAL, LLC 661,490$6,284,0000.91%
KNOTT DAVID M 158,555$1,665,0000.71%
Perceptive Advisors 3,098,010$32,530,0000.62%
Sio Capital Management, LLC 91,413$960,0000.50%
HEARTLAND ADVISORS INC 700,000$7,350,0000.48%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders